{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:03:49Z","timestamp":1786125829637,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fondation ARC Jeunes Chercheurs"},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"DOI":"10.1007\/s10456-026-10073-5","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:28:13Z","timestamp":1786116493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments"],"prefix":"10.1007","volume":"29","author":[{"given":"No\u00e9mie","family":"Brassard-Jollive","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille L. M.","family":"Comp\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Ardidie-Robouant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad","family":"El Bouchtaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lelarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Josseaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Helary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Sibony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Monnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"10073_CR1","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M et al (2017) Renal cell carcinoma. Nat Rev Dis Primer 3:17009","journal-title":"Nat Rev Dis Primer"},{"key":"10073_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1158\/1535-7163.MCT-14-0094","volume":"14","author":"E Ciamporcero","year":"2015","unstructured":"Ciamporcero E, Miles KM, Adelaiye R, Ramakrishnan S, Shen L, Ku S et al (2015) Combination strategy targeting VEGF and HGF\/c-met in human renal cell carcinoma models. Mol Cancer Ther 14:101\u2013110","journal-title":"Mol Cancer Ther"},{"key":"10073_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/jnci\/94.12.883","volume":"94","author":"L Hlatky","year":"2002","unstructured":"Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn\u2019t tell us. J Natl Cancer Inst 94:883\u2013893","journal-title":"J Natl Cancer Inst"},{"key":"10073_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15252\/emmm.201404271","volume":"7","author":"A McIntyre","year":"2015","unstructured":"McIntyre A, Harris AL (2015) Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med 7:368\u2013379","journal-title":"EMBO Mol Med"},{"key":"10073_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1053\/hupa.2001.28957","volume":"32","author":"N Rioux-Leclercq","year":"2001","unstructured":"Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A et al (2001) Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 32:1209\u20131215","journal-title":"Hum Pathol"},{"key":"10073_CR6","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/sj.bjc.6603796","volume":"96","author":"MM Baldewijns","year":"2007","unstructured":"Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T et al (2007) High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer 96:1888\u20131895","journal-title":"Br J Cancer"},{"key":"10073_CR7","first-page":"127","volume":"53","author":"G Anastassiou","year":"1996","unstructured":"Anastassiou G, Duensing S, Steinhoff G, Zorn U, Grosse J, Dallmann I et al (1996) Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology 53:127\u2013132","journal-title":"Oncology"},{"key":"10073_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12253-017-0262-y","volume":"24","author":"A Ruiz-Saur\u00ed","year":"2018","unstructured":"Ruiz-Saur\u00ed A, Garc\u00eda-Bustos V, Granero E, Cuesta S, Sales MA, Marcos V et al (2018) Distribution of vascular patterns in different subtypes of renal cell carcinoma. A morphometric study in two distinct types of blood vessels. Pathol Oncol Res 24:515\u2013524","journal-title":"Pathol Oncol Res"},{"key":"10073_CR9","first-page":"533","volume":"7","author":"E Sabo","year":"2001","unstructured":"Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7:533\u2013537","journal-title":"Clin Cancer Res"},{"key":"10073_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: New dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"10073_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","volume":"49","author":"F Kai","year":"2019","unstructured":"Kai F, Drain AP, Weaver VM (2019) The extracellular matrix modulates the metastatic journey. Dev Cell 49:332\u2013346","journal-title":"Dev Cell"},{"key":"10073_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s44164-022-00040-x","volume":"1","author":"F Weiss","year":"2022","unstructured":"Weiss F, Atlasy N, van Reijmersdal V, Stunnenberg H, Hulsbergen-Veelken C, Friedl P (2022) 3D spheroid culture to examine adaptive therapy response in invading tumor cells. Vitro Models 1:463\u2013471","journal-title":"Vitro Models"},{"key":"10073_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A et al (2022) Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55:527\u2013541","journal-title":"Immunity"},{"key":"10073_CR14","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-22-3034","volume":"83","author":"G Davidson","year":"2023","unstructured":"Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M et al (2023) Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma. Cancer Res 83:2952\u20132969","journal-title":"Cancer Res"},{"key":"10073_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s42003-024-06478-x","volume":"7","author":"J Zvirblyte","year":"2024","unstructured":"Zvirblyte J, Nainys J, Juzenas S, Goda K, Kubiliute R, Dasevicius D et al (2024) Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype. Commun Biol 7:780","journal-title":"Commun Biol"},{"key":"10073_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","volume":"22","author":"RJ Motzer","year":"2024","unstructured":"Motzer RJ, Jonasch E, Agarwal N, Alva A, Bagshaw H, Baine M et al (2024) NCCN Guidelines\u00ae Insights: Kidney Cancer, Version 2.2024. J Natl Compr Cancer Netw 22:4\u201316","journal-title":"J Natl Compr Cancer Netw"},{"key":"10073_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","volume":"87","author":"R Barragan-Carrillo","year":"2025","unstructured":"Barragan-Carrillo R, Saad E, Saliby RM, Sun M, Albiges L, Bex A et al (2025) First and second-line treatments in metastatic renal cell carcinoma. Eur Urol 87:143\u2013154","journal-title":"Eur Urol"},{"key":"10073_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/02841860802609574","volume":"48","author":"P Wolter","year":"2009","unstructured":"Wolter P, Beuselinck B, Pans S, Sch\u00f6ffski P (2009) Flare-up: an often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors. Acta Oncol Stockh Swed 48:621\u2013624","journal-title":"Acta Oncol Stockh Swed"},{"key":"10073_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.20517\/cdr.2023.33","volume":"6","author":"S Astore","year":"2023","unstructured":"Astore S, Baciarello G, Cerbone L, Calabr\u00f2 F (2023) Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. Cancer Drug Resist 6:517\u2013546","journal-title":"Cancer Drug Resist"},{"key":"10073_CR20","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-16-0035","volume":"22","author":"MH Voss","year":"2016","unstructured":"Voss MH, Hsieh JJ (2016) Therapeutic guide for mTOuRing through the braided kidney cancer genomic river. Clin Cancer Res 22:2320\u20132322","journal-title":"Clin Cancer Res"},{"key":"10073_CR21","doi-asserted-by":"publisher","first-page":"594903","DOI":"10.3389\/fcell.2020.594903","volume":"8","author":"N Brassard-Jollive","year":"2020","unstructured":"Brassard-Jollive N, Monnot C, Muller L, Germain S (2020) In vitro 3D systems to model tumor angiogenesis and interactions with stromal cells. Front Cell Dev Biol 8:594903","journal-title":"Front Cell Dev Biol"},{"key":"10073_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-016-0565-8","volume":"15","author":"KK Brodaczewska","year":"2016","unstructured":"Brodaczewska KK, Szczylik C, Fiedorowicz M, Porta C, Czarnecka AM (2016) Choosing the right cell line for renal cell cancer research. Mol Cancer 15:83","journal-title":"Mol Cancer"},{"key":"10073_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271\u2013275","journal-title":"Nature"},{"key":"10073_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000444533","volume":"83","author":"G Bousquet","year":"2016","unstructured":"Bousquet G, Janin A (2016) Patient-derived xenograft: an adjuvant technology for the treatment of metastatic disease. Pathobiol J Immunopathol Mol Cell Biol 83:170\u2013176","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"10073_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/cancers12020439","volume":"12","author":"AT Tracey","year":"2020","unstructured":"Tracey AT, Murray KS, Coleman JA, Kim K (2020) Patient-derived xenograft models in urological malignancies: urothelial cell carcinoma and renal cell carcinoma. Cancers 12:439","journal-title":"Cancers"},{"key":"10073_CR26","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.ajpath.2016.05.019","volume":"186","author":"V Di Stefano","year":"2016","unstructured":"Di Stefano V, Torsello B, Bianchi C, Cifola I, Mangano E, Bovo G et al (2016) Major action of endogenous lysyl oxidase in clear cell renal cell carcinoma progression and collagen stiffness revealed by primary cell cultures. Am J Pathol 186:2473\u20132485","journal-title":"Am J Pathol"},{"key":"10073_CR27","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1158\/1541-7786.MCR-14-0233","volume":"12","author":"H Hase","year":"2014","unstructured":"Hase H, Jingushi K, Ueda Y, Kitae K, Egawa H, Ohshio I et al (2014) LOXL2 status correlates with tumor stage and regulates integrin levels to promote tumor progression in ccRCC. Mol Cancer Res 12:1807\u20131817","journal-title":"Mol Cancer Res"},{"key":"10073_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/biomedicines10020206","volume":"10","author":"A Liabotis","year":"2022","unstructured":"Liabotis A, Ardidie-Robouant C, Mailly P, Besbes S, Gutierrez C, Atlas Y et al (2022) Angiopoietin-like 4-induced 3D capillary morphogenesis correlates to stabilization of endothelial adherens junctions and restriction of VEGF-induced sprouting. Biomedicines 10:206","journal-title":"Biomedicines"},{"key":"10073_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1158\/1078-0432.CCR-09-1385","volume":"16","author":"D Mahalingam","year":"2010","unstructured":"Mahalingam D, Medina EC, Esquivel JA, Espitia CM, Smith S, Oberheu K et al (2010) Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels. Clin Cancer Res 16:141\u2013153","journal-title":"Clin Cancer Res"},{"key":"10073_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1096\/fj.201800596R","volume":"33","author":"Z Lichner","year":"2019","unstructured":"Lichner Z, Saleeb R, Butz H, Ding Q, Nofech-Mozes R, Riad S et al (2019) Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance. FASEB J 33:1347\u20131359","journal-title":"FASEB J"},{"key":"10073_CR31","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.7150\/thno.41001","volume":"10","author":"L Fabbri","year":"2020","unstructured":"Fabbri L, Dufies M, Lacas-Gervais S, Gardie B, Gad-Lapiteau S, Parola J et al (2020) Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-\u2206C in clear cell renal cell carcinoma patients. Theranostics 10:2696\u20132713","journal-title":"Theranostics"},{"key":"10073_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","volume":"24","author":"S Faivre","year":"2006","unstructured":"Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N et al (2006) Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 24:25\u201335","journal-title":"J Clin Oncol"},{"key":"10073_CR33","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1158\/0008-5472.CAN-04-4406","volume":"65","author":"D Zagzag","year":"2005","unstructured":"Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA et al (2005) Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65:6178\u20136188","journal-title":"Cancer Res"},{"key":"10073_CR34","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1158\/0008-5472.CAN-16-3190","volume":"77","author":"P Marona","year":"2017","unstructured":"Marona P, G\u00f3rka J, Mazurek Z, Wilk W, Rys J, Majka M et al (2017) MCPIP1 downregulation in clear cell renal cell carcinoma promotes vascularization and metastatic progression. Cancer Res 77:4905\u20134920","journal-title":"Cancer Res"},{"key":"10073_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1078-0432.CCR-06-0774","volume":"13","author":"X Yao","year":"2007","unstructured":"Yao X, Qian CN, Zhang ZF, Tan MH, Kort EJ, Yang XJ et al (2007) Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 13:161\u2013169","journal-title":"Clin Cancer Res"},{"key":"10073_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5114\/pjp.2016.59477","volume":"67","author":"O Ferician","year":"2016","unstructured":"Ferician O, Cimpean AM, Ceausu AR, Dema A, Raica M, Cumpanas A (2016) Heterogeneous vascular patterns in renal cell carcinomas. Pol J Pathol 67:46\u201353","journal-title":"Pol J Pathol"},{"key":"10073_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00428-021-03214-2","volume":"479","author":"S Canete-Portillo","year":"2021","unstructured":"Canete-Portillo S, Rodriguez Pena MDC, Wang D, Sanchez DF, Netto GJ, Magi-Galluzzi C (2021) Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma. Virchows Arch 479:1187\u20131196","journal-title":"Virchows Arch"},{"key":"10073_CR38","doi-asserted-by":"publisher","first-page":"e12388","DOI":"10.1002\/2056-4538.12388","volume":"10","author":"Y Kaneko","year":"2024","unstructured":"Kaneko Y, Masuda T, Takamatsu K, Mikami S, Nakamura K, Nishihara H et al (2024) Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma. J Pathol Clin Res 10:e12388","journal-title":"J Pathol Clin Res"},{"key":"10073_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-018-9613-x","volume":"21","author":"P Nowak-Sliwinska","year":"2018","unstructured":"Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R et al (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425\u2013532","journal-title":"Angiogenesis"},{"key":"10073_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW (2023) Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis 26:313\u2013347","journal-title":"Angiogenesis"},{"key":"10073_CR41","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-05-2670","volume":"66","author":"MA Esteban","year":"2006","unstructured":"Esteban MA, Tran MGB, Harten SK, Hill P, Castellanos MC, Chandra A et al (2006) Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res 66:3567\u20133575","journal-title":"Cancer Res"},{"key":"10073_CR42","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-05-3719","volume":"66","author":"B Krishnamachary","year":"2006","unstructured":"Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH et al (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66:2725\u20132731","journal-title":"Cancer Res"},{"key":"10073_CR43","first-page":"71","volume":"6","author":"P Cossu-Rocca","year":"2016","unstructured":"Cossu-Rocca P, Muroni MR, Sanges F, Sotgiu G, Asunis A, Tanca L et al (2016) EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma. Am J Cancer Res 6:71\u201383","journal-title":"Am J Cancer Res"},{"key":"10073_CR44","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/j.neo.2023.100948","volume":"46","author":"CP Miller","year":"2023","unstructured":"Miller CP, Fung M, Jaeger-Ruckstuhl CA, Xu Y, Warren EH, Akilesh S et al (2023) Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system. Neoplasia 46:100948","journal-title":"Neoplasia"},{"key":"10073_CR45","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C et al (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4:998\u20131013","journal-title":"Cancer Discov"},{"key":"10073_CR46","doi-asserted-by":"publisher","first-page":"1139049","DOI":"10.3389\/fonc.2023.1139049","volume":"13","author":"M Takeda","year":"2023","unstructured":"Takeda M, Sakamoto H, Shibasaki N, Fukui T, Magaribuchi T, Sumiyoshi T et al (2023) Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model. Front Oncol 13:1139049","journal-title":"Front Oncol"},{"key":"10073_CR47","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1158\/0008-5472.CAN-21-0345","volume":"81","author":"HH Nguyen-Tran","year":"2021","unstructured":"Nguyen-Tran HH, Nguyen TN, Chen CY, Hsu T (2021) Endothelial reprogramming stimulated by oncostatin M promotes inflammation and tumorigenesis in VHL-deficient kidney tissue. Cancer Res 81:5060\u20135073","journal-title":"Cancer Res"},{"key":"10073_CR48","doi-asserted-by":"publisher","first-page":"e970","DOI":"10.1002\/ctm2.970","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Xu H, Yu L, Wang J, Meng Q, Mei H et al (2022) Patient-derived renal cell carcinoma organoids for personalized cancer therapy. Clin Transl Med 12:e970","journal-title":"Clin Transl Med"},{"key":"10073_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1158\/1535-7163.MCT-14-0208","volume":"14","author":"R Adelaiye","year":"2015","unstructured":"Adelaiye R, Ciamporcero E, Miles KM, Sotomayor P, Bard J, Tsompana M et al (2015) Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications. Mol Cancer Ther 14:513\u2013522","journal-title":"Mol Cancer Ther"},{"key":"10073_CR50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.aat1699","volume":"361","author":"MD Young","year":"2018","unstructured":"Young MD, Mitchell TJ, Vieira Braga FA, Tran MGB, Stewart BJ, Ferdinand JR et al (2018) Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science 361:594\u2013599","journal-title":"Science"},{"key":"10073_CR51","doi-asserted-by":"publisher","first-page":"e2103240118","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P et al (2021) Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci U S A 118:e2103240118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10073_CR52","doi-asserted-by":"publisher","first-page":"719564","DOI":"10.3389\/fonc.2021.719564","volume":"11","author":"C Su","year":"2021","unstructured":"Su C, Lv Y, Lu W, Yu Z, Ye Y, Guo B et al (2021) Single-cell rna sequencing in multiple pathologic types of renal cell carcinoma revealed novel potential tumor-specific markers. Front Oncol 11:719564","journal-title":"Front Oncol"},{"key":"10073_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s44276-024-00047-9","volume":"2","author":"Y Xu","year":"2024","unstructured":"Xu Y, Miller CP, Xue J, Zheng Y, Warren EH, Tykodi SS et al (2024) Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes. BJC Rep 2:23","journal-title":"BJC Rep"},{"key":"10073_CR54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41374-019-0188-y","volume":"99","author":"HS Hwang","year":"2019","unstructured":"Hwang HS, Go H, Park JM, Yoon SY, Lee JL, Jeong SU et al (2019) Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma. Lab Investig J Tech Methods Pathol 99:659\u2013670","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10073_CR55","first-page":"2950","volume":"7","author":"M Varna","year":"2014","unstructured":"Varna M, Bousquet G, Ferreira I, Goulard M, El-Bouchtaoui M, Artus PM et al (2014) Stability of preclinical models of aggressive renal cell carcinomas. Int J Clin Exp Pathol 7:2950\u20132962","journal-title":"Int J Clin Exp Pathol"},{"key":"10073_CR56","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1158\/1078-0432.CCR-14-0666","volume":"21","author":"M Varna","year":"2015","unstructured":"Varna M, Gapihan G, Feugeas JP, Ratajczak P, Tan S, Ferreira I et al (2015) Stem cells increase in numbers in perinecrotic areas in human renal cancer. Clin Cancer Res 21:916\u2013924","journal-title":"Clin Cancer Res"},{"key":"10073_CR57","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jmb.2007.12.047","volume":"376","author":"F Gobeaux","year":"2008","unstructured":"Gobeaux F, Mosser G, Anglo A, Panine P, Davidson P, Giraud-Guille MM et al (2008) Fibrillogenesis in dense collagen solutions: a physicochemical study. J Mol Biol 376:1509\u20131522","journal-title":"J Mol Biol"},{"key":"10073_CR58","doi-asserted-by":"publisher","first-page":"120594","DOI":"10.1016\/j.biomaterials.2020.120594","volume":"268","author":"Y Atlas","year":"2021","unstructured":"Atlas Y, Gorin C, Novais A, Marchand MF, Chatzopoulou E, Lesieur J et al (2021) Microvascular maturation by mesenchymal stem cells in vitro improves blood perfusion in implanted tissue constructs. Biomaterials 268:120594","journal-title":"Biomaterials"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-026-10073-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:02:16Z","timestamp":1786122136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-026-10073-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["10073"],"URL":"https:\/\/doi.org\/10.1007\/s10456-026-10073-5","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}